FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

S Gauthier

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Geographic Areas

Canada

Physiology

Co-author Network

Publications

TOP 3
Nathan Herrmann; Neli Boneva; S Gauthier; Ole Michael Lemming
A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease.
Francis Clément; S Gauthier; Sylvie Belleville
Executive functions in mild cognitive impairment: Emergence and breakdown of neural plasticity.
Vjera Holthoff; Ralf Ihl; Philippe Robert; Kati Sternberg; Frank Tennigkeit; Bengt Winblad; Steven Ferris; S Gauthier
Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of S Gauthier (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Nathan Herrmann; Neli Boneva; S Gauthier; Ole Michael Lemming
A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease.
International psychogeriatrics / IPA 2013;25(6):919-27.
2013: Francis Clément; S Gauthier; Sylvie Belleville
Executive functions in mild cognitive impairment: Emergence and breakdown of neural plasticity.
Cortex; a journal devoted to the study of the nervous system and behavior 2013;49(5):1268-79.
2013: Vjera Holthoff; Ralf Ihl; Philippe Robert; Kati Sternberg; Frank Tennigkeit; Bengt Winblad; Steven Ferris; S Gauthier
Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical study.
International journal of geriatric psychiatry 2013;28(2):164-72.
2012: S Gauthier; Michael Gordon; Nathan Herrmann; Christopher Patterson; Kenneth Rockwood; Pedro Rosa-Neto; Howard Chertkow; Jean-Paul Soucy
Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4).
Canadian geriatrics journal : CGJ 2012;15(4):120-6.
2012: Liyong Wu; Sandra E Black; Ging-Yuek R Hsiung; Jianping Jia; Mario Masellis; Pedro Rosa-Neto; A Dessa Sadovnick; S Gauthier
Early-onset familial Alzheimer's disease (EOFAD).
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2012;39(4):436-45.
2012: Antoine Leuzy; S Gauthier
Ethical issues in Alzheimer's disease: an overview.
Expert review of neurotherapeutics 2012;12(5):557-67.
2012: Frédéric Peters; Marc Verny; Bénédicte Dieudonné; Anne-Marie Ergis; S Gauthier; Pierre Jolicoeur; Sylvie Belleville
Abnormal temporal dynamics of visual attention in Alzheimer's disease and in dementia with Lewy bodies.
Neurobiology of aging 2012;33(5):1012.e1-10.
2012: Ralf Ihl; Philippe Robert; Steven Ferris; S Gauthier; Bengt Winblad; Frank Tennigkeit
Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease.
International journal of geriatric psychiatry 2012;27(1):15-21.
2011: Sylvia Villeneuve; Christian Bocti; S Gauthier; Fadi Massoud; Sylvie Belleville
The nature of episodic memory deficits in MCI with and without vascular burden.
Neuropsychologia 2011;49(11):3027-35.
2011: Sylvie Belleville; Francis Clément; Samira Mellah; Brigitte Gilbert; Francine Fontaine; S Gauthier
Training-related brain plasticity in subjects at risk of developing Alzheimer's disease.
Brain : a journal of neurology 2011;134(Pt 6):1623-34.
2011: S Gauthier; Christopher Patterson; Michael Gordon; Jean-Paul Soucy; François Schubert; Antoine Leuzy
Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." A Canadian perspective.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2011;7(3):330-2.
2011: Fadi Massoud; Julie Eve Desmarais; S Gauthier
Switching cholinesterase inhibitors in older adults with dementia.
International psychogeriatrics / IPA 2011;23(3):372-8.
2011: Clive G Ballard; S Gauthier; Anne Corbett; Carol Brayne; Dag Aarsland; Emma Jones
Alzheimer's disease.
Lancet 2011;377(9770):1019-31.
2011: Paul S Aisen; Anh Duong; Steven H Ferris; Denis Garceau; S Gauthier; Denis Haine; Wan C Lau; Joonmi Oh; Daniel Saumier; Joyce Suhy; John Sampalis
Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study).
Archives of medical science : AMS 2011;7(1):102-11.
2011: Gunhild Waldemar; S Gauthier; Roy Jones; David Wilkinson; Jeffrey L Cummings; Oscar L Lopez; Richard Zhang; Yikang Xu; Yijun Sun; Sean Knox; Sharon Richardson; Joan Mackell
Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease.
International journal of geriatric psychiatry 2011;26(2):150-7.
2011: Vjera A Holthoff; Ralf Ihl; Philippe Robert; Kati Sternberg; Steven Ferris; S Gauthier; Bengt Winblad; Frank Tennigkeit
Validation of the relevant outcome scale for Alzheimer's disease: a novel multidomain assessment for daily medical practice.
Alzheimer's research & therapy 2011;3(5):27.
2010: Bengt Winblad; S Gauthier; D Aström; K Stender
Memantine benefits functional abilities in moderate to severe Alzheimer's disease.
The journal of nutrition, health & aging 2010;14(9):770-4.
2010: Oscar L Lopez; Elias Schwam; Jeffrey L Cummings; S Gauthier; Roy Jones; David Wilkinson; Gunhild Waldemar; Richard Zhang; Rachel Schindler
Predicting cognitive decline in Alzheimer's disease: an integrated analysis.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2010;6(6):431-9.
2010: Bruno Dubois; Howard H Feldman; Claudia Jacova; Jeffrey L Cummings; Steven T DeKosky; Pascale Barberger-Gateau; André Delacourte; Giovanni B Frisoni; Nick C Fox; Douglas Galasko; S Gauthier; Harald Hampel; Gregory A Jicha; Kenichi Meguro; John O'Brien; Florence Pasquier; Philippe Robert; Martin N Rossor; Steven Salloway; Marie Sarazin; Leonardo C de Souza; Yaakov Stern; Pieter J Visser; Philip scheltens
Revising the definition of Alzheimer's disease: a new lexicon.
Lancet neurology 2010;9(11):1118-27.
2010: Martin R Farlow; George Grossberg; S Gauthier; Xiangyi Meng; Jason T Olin
The ACTION study: methodology of a trial to evaluate safety and efficacy of a higher dose rivastigmine transdermal patch in severe Alzheimer's disease.
Current medical research and opinion 2010;26(10):2441-7.
2010: KATHRYN DE MEDEIROS; P Robert; S Gauthier; F Stella; Antonios M Politis; Jeanniemarie Leoutsakos; F Taragano; J Kremer; A Brugnolo; A P Porsteinsson; Y E Geda; H Brodaty; G Gazdag; Jeffrey L Cummings; Constantine G Lyketsos
The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia.
International psychogeriatrics / IPA 2010;22(6):984-94.
2010: S Gauthier; Oscar L Lopez; Gunhild Waldemar; Roy W Jones; Jeffrey L Cummings; Richard Zhang; Rachel Schindler; Elias Schwam
Effects of donepezil on activities of daily living: integrated analysis of patient data from studies in mild, moderate and severe Alzheimer's disease.
International psychogeriatrics / IPA 2010;22(6):973-83.
2010: B C Healy; Maria Liguori; D Tran; Tanuja Chitnis; B Glanz; C Wolfish; S Gauthier; Guy J Buckle; M Houtchens; L Stazzone; S Khoury; R Hartzmann; M Fernandez-Vina; David A Hafler; Howard L Weiner; Charles R G Guttmann; Philip De Jager
HLA B*44: protective effects in MS susceptibility and MRI outcome measures.
Neurology 2010;75(7):634-40.
2010: Julie Eve Desmarais; S Gauthier
Alzheimer disease: clinical use of cholinergic drugs in Alzheimer disease.
Nature reviews. Neurology 2010;6(8):418-20.
2010: Sandra E Black; S Gauthier; William Dalziel; Ron Keren; Jane Correia; Huong Hew; Carin Binder
Canadian Alzheimer's disease caregiver survey: baby-boomer caregivers and burden of care.
International journal of geriatric psychiatry 2010;25(8):807-13.
2010: S Gauthier; Angela Garcia; Mary Sano; Philippe Robert; Vorapun Senanarong; Michael Woodward; Henry Brodaty
Priorities for research consortia on Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2010;6(4):359-62.
2010: S Gauthier; Angela Juby; William Dalziel; Bonita Réhel; Robyn Schecter
Effects of rivastigmine on common symptomatology of Alzheimer's disease (EXPLORE).
Current medical research and opinion 2010;26(5):1149-60.
2010: S Gauthier; Jeffrey L Cummings; Clive G Ballard; Henry Brodaty; George Grossberg; Philippe Robert; Constantine G Lyketsos
Management of behavioral problems in Alzheimer's disease.
International psychogeriatrics / IPA 2010;22(3):346-72.
2010: S Gauthier; B Le Creurer
Compressibility effects in Rayleigh-Taylor instability-induced flows.
Philosophical transactions. Series A, Mathematical, physical, and engineering sciences 2010;368(1916):1681-704.
2010: Fadi Massoud; S Gauthier
Update on the pharmacological treatment of Alzheimer's disease.
Current neuropharmacology 2010;8(1):69-80.
2010: Greg L Plosker; S Gauthier
Spotlight on cerebrolysin in dementia.
CNS drugs 2010;24(3):263-6.
2010: Julie E Davidson; Michael C Irizarry; Bethany C Bray; Sally Wetten; Nicholas Galwey; Rachel Gibson; Michael Borrie; Richard Delisle; Howard H Feldman; Ging-Yuek Hsiung; Luis Fornazzari; S Gauthier; Danilo Guzman; Inge Loy-English; Ron Keren; Andrew Kertesz; Peter St George-Hyslop; John Wherrett; Andreas U Monsch
An exploration of cognitive subgroups in Alzheimer's disease.
Journal of the International Neuropsychological Society : JINS 2010;16(2):233-43.
2010: Paige Moorhouse; Xiaowei Song; Kenneth Rockwood; Sandra Black; Andrew Kertesz; S Gauthier; Howard Feldman
Executive dysfunction in vascular cognitive impairment in the consortium to investigate vascular impairment of cognition study.
Journal of the neurological sciences 2010;288(1-2):142-6.
2010: Philippe Robert; Steven Ferris; S Gauthier; Ralf Ihl; Bengt Winblad; Frank Tennigkeit
Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice?
Alzheimer's research & therapy 2010;2(4):24.
2010: Jeffrey L Cummings; Roy Jones; David Wilkinson; Oscar L Lopez; S Gauthier; Gunhild Waldemar; Richard Zhang; Yikang Xu; Yijun Sun; Sharon Richardson; Joan Mackell
Effect of donepezil on cognition in severe Alzheimer's disease: a pooled data analysis.
Journal of Alzheimer's disease : JAD 2010;21(3):843-51.
2010: S Gauthier; Antoine Leuzy
Diagnosis of prodromal Alzheimer's disease: do you really want to know?
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2010;37(1):2.
2010: Sara Bélanger; Sylvie Belleville; S Gauthier
Inhibition impairments in Alzheimer's disease, mild cognitive impairment and healthy aging: effect of congruency proportion in a Stroop task.
Neuropsychologia 2010;48(2):581-90.
2009: Guk-Hee Suh; Anders Wimo; S Gauthier; Daniel O'Connor; Manabu Ikeda; Akira Homma; Jacqueline Dominguez; Bong-Min Yang
International price comparisons of Alzheimer's drugs: a way to close the affordability gap.
International psychogeriatrics / IPA 2009;21(6):1116-26.
2009: S Gauthier
Psychopharmacology for the clinician: should we treat patients with verymild Alzheimer disease with acholinesterase inhibitor?.
Journal of psychiatry & neuroscience : JPN 2009;34(6):480.
2009: S Gauthier; Philip scheltens
Can we do better in developing new drugs for Alzheimer's disease?
Alzheimer's & dementia : the journal of the Alzheimer's Association 2009;5(6):489-91.
2009: Steven Ferris; Ralf Ihl; Philippe Robert; Bengt Winblad; Gudrun Gatz; Frank Tennigkeit; S Gauthier
Severe Impairment Battery Language scale: a language-assessment tool for Alzheimer's disease patients.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2009;5(5):375-9.
2009: Steven Ferris; Ralf Ihl; Philippe Robert; Bengt Winblad; Gudrun Gatz; Frank Tennigkeit; S Gauthier
Treatment effects of Memantine on language in moderate to severe Alzheimer's disease patients.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2009;5(5):369-74.
2009: ZAVEN KHACHATURIAN; Jordi Camí; Sandrine Andrieu; Jesús Avila; Mercè Boada Rovira; Monique Breteler; Lutz Froelich; S Gauthier; Teresa Gómez-Isla; Ara Khachaturian; Lewis H Kuller; Eric B Larson; Oscar L Lopez; José Manuel Martinez-Lage; Ronald C. Petersen; Gerard D Schellenberg; Jordi Sunyer; Bruno Vellas; Lisa J Bain
Creating a transatlantic research enterprise for preventing Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2009;5(4):361-6.
2009: S Gauthier
Will CSF analysis become routine in people with memory complaints?
Lancet neurology 2009;8(7):595-6.
2009: S Gauthier; Paul S Aisen; S H Ferris; D Saumier; A Duong; Denis Haine; D Garceau; J Suhy; J Oh; W Lau; J Sampalis
Effect of tramiprosate in patients with mild-to-moderate Alzheimer's disease: exploratory analyses of the MRI sub-group of the Alphase study.
The journal of nutrition, health & aging 2009;13(6):550-7.
2009: S Gauthier; John T O'Brien
Top cited papers in international psychogeriatrics: 3. Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease.
International psychogeriatrics / IPA 2009;21(3):454-6.
2009: Carol Hudon; Sylvie Belleville; S Gauthier
The assessment of recognition memory using the Remember/Know procedure in amnestic mild cognitive impairment and probable Alzheimer's disease.
Brain and cognition 2009;70(1):171-9.
2009: Clive G Ballard; S Gauthier; Jeffrey L Cummings; Henry Brodaty; George T Grossberg; Philippe Robert; Constantine G Lyketsos
Management of agitation and aggression associated with Alzheimer disease.
Nature reviews. Neurology 2009;5(5):245-55.
2009: D Saumier; Paul S Aisen; S Gauthier; Bruno Vellas; S H Ferris; A Duong; J Suhy; J Oh; W Lau; D Garceau; Denis Haine; J Sampalis
Lessons learned in the use of volumetric MRI in therapeutic trials in Alzheimer's disease: the ALZHEMED (Tramiprosate) experience.
The journal of nutrition, health & aging 2009;13(4):370-2.
2009: S Gauthier; Judes Poirier
Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease?
Alzheimer's & dementia : the journal of the Alzheimer's Association 2009;5(2):147-8.
2009: ZAVEN KHACHATURIAN; Peter J Snyder; Rachelle S Doody; Paul S Aisen; Meryl Comer; John Dwyer; Richard A Frank; Andrew Holzapfel; Ara Khachaturian; Amos D Korczyn; Allen D Roses; James W Simpkins; Lon S Schneider; Marilyn S Albert; Robert Egge; Aaron Deves; Steven Ferris; Barry D Greenberg; Carl Johnson; Walter A Kukull; Judes Poirier; Dale Schenk; William Thies; S Gauthier; Sid Gilman; Charles Bernick; Jeffrey L Cummings; Howard Fillit; Michael Grundman; Jeffrey A Kaye; Lennart Mucke; Barry Reisberg; Mary Sano; Oxana Pickeral; Ronald C. Petersen; Richard C Mohs; Maria Carrillo; Jody Corey-Bloom; Norman L Foster; Steve Jacobsen; Virginia M-Y Lee; William Z Potter; Marwan Sabbagh; David P Salmon; John Q Trojanowski; Nancy Wexler; Lisa J Bain
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2009;5(2):85-92.
2009: S Gauthier
Editorial: CTAD International Research Conference: Clinical Trials in Alzheimer's Disease.
The journal of nutrition, health & aging 2009;13(3):204.
2009: Philippe Robert; CHIADIKAOBI ONYIKE; A F G Leentjens; K Dujardin; P Aalten; S Starkstein; F R J Verhey; J Yessavage; J P Clement; D Drapier; F Bayle; M Benoit; P Boyer; P M Lorca; F Thibaut; S Gauthier; G Grossberg; Bruno Vellas; J Byrne
Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders.
European psychiatry : the journal of the Association of European Psychiatrists 2009;24(2):98-104.
2009: S Gauthier
Dimebon improves cognitive function in people with mild to moderate Alzheimer's disease.
Evidence-based mental health 2009;12(1):21.
2009: Simona Maria Brambati; Sylvie Belleville; Marie-Jeanne Kergoat; Céline Chayer; S Gauthier; Sven Joubert
Single- and multiple-domain amnestic mild cognitive impairment: two sides of the same coin?
Dementia and geriatric cognitive disorders 2009;28(6):541-9.
2009: Greg L Plosker; S Gauthier
Cerebrolysin: a review of its use in dementia.
Drugs & aging 2009;26(11):893-915.
2009: David Wilkinson; Rachel Schindler; Elias Schwam; Gunhild Waldemar; Roy W Jones; S Gauthier; Oscar L Lopez; Jeffrey L Cummings; Yikang Xu; Howard H Feldman
Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate alzheimer's disease.
Dementia and geriatric cognitive disorders 2009;28(3):244-51.
2009: Sylvia Villeneuve; Sylvie Belleville; Fadi Massoud; Christian Bocti; S Gauthier
Impact of vascular risk factors and diseases on cognition in persons with mild cognitive impairment.
Dementia and geriatric cognitive disorders 2009;27(4):375-81.
2009: Sandrine Andrieu; Nicola Coley; Paul S Aisen; Maria C Carrillo; Steven T DeKosky; Jane Durga; Howard Fillit; Giovanni B Frisoni; Lutz Froelich; S Gauthier; Roy Jones; Linus Jönsson; ZAVEN KHACHATURIAN; John C Morris; Jean-Marc Orgogozo; Pierre-Jean Ousset; Philippe Robert; Eric Salmon; Cristina Sampaio; Frans Verhey; Gordon K Wilcock; Bruno Vellas
Methodological issues in primary prevention trials for neurodegenerative dementia.
Journal of Alzheimer's disease : JAD 2009;16(2):235-70.
2009: S Gauthier
Pharmacotherapy of Parkinson disease dementia and Lewy body dementia.
Frontiers of neurology and neuroscience 2009;24():135-9.
2009: Timo Erkinjuntti; S Gauthier
The concept of vascular cognitive impairment.
Frontiers of neurology and neuroscience 2009;24():79-85.
2008: Nathan Herrmann; S Gauthier
Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2008;179(12):1279-87.
2008: Werner Poewe; S Gauthier; Dag Aarsland; James B Leverenz; P Barone; D Weintraub; E Tolosa; Bruno Dubois
Diagnosis and management of Parkinson's disease dementia.
International journal of clinical practice 2008;62(10):1581-7.
2008: Timo Erkinjuntti; S Gauthier; R Bullock; Alexander Kurz; G Hammond; S Schwalen; Y Zhu; R Brashear
Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6).
Journal of psychopharmacology (Oxford, England) 2008;22(7):761-8.
2008: S Gauthier; Bruno Dubois; Howard Feldman; Philip scheltens
Revised research diagnostic criteria for Alzheimer's disease.
Lancet neurology 2008;7(8):668-70.
2008: Carol Hudon; Sylvie Belleville; S Gauthier
The association between depressive and cognitive symptoms in amnestic mild cognitive impairment.
International psychogeriatrics / IPA 2008;20(4):710-23.
2008: Bengt Winblad; S Gauthier; L Scinto; H Feldman; Gordon K Wilcock; L Truyen; A J Mayorga; D Wang; H R Brashear; J S Nye
Safety and efficacy of galantamine in subjects with mild cognitive impairment.
Neurology 2008;70(22):2024-35.
2008: ZAVEN KHACHATURIAN; Ronald C. Petersen; S Gauthier; Neil Buckholtz; Jody Corey-Bloom; Bill Evans; Howard Fillit; Norman Foster; Barry Greenberg; Michael Grundman; Mary Sano; James Simpkins; Lon S Schneider; Michael Weiner; Douglas Galasko; Bradley T Hyman; Lew Kuller; Dale Schenk; Stephen Snyder; Ronald Thomas; Mark H Tuszynski; Bruno Vellas; Richard J Wurtman; Peter J Snyder; Richard A Frank; Marilyn S Albert; Rachelle S Doody; Steven H Ferris; Jeffrey A Kaye; Edward H Koo; Marcelle Morrison-Bogorad; Barry Reisberg; David P Salmon; Sid Gilman; Richard C Mohs; Paul S Aisen; John C S Breitner; Jeffrey L Cummings; Claudia Kawas; Creighton Phelps; Judes Poirier; Marwan Sabbagh; Jacques Touchon; Ara Khachaturian; Lisa J Bain
A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2008;4(3):156-63.
2008: S Gauthier; H Loft; Jeffrey L Cummings
Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis.
International journal of geriatric psychiatry 2008;23(5):537-45.
2008: P Maurage; S Campanella; P Philippot; P de Timary; E Constant; S Gauthier; M-L Miccichè; C Kornreich; C Hanak; X Noel; P Verbanck
Alcoholism leads to early perceptive alterations, independently of comorbid depressed state: an ERP study.
Neurophysiologie clinique = Clinical neurophysiology 2008;38(2):83-97.
2008: Francis Clément; Sylvie Belleville; S Gauthier
Cognitive complaint in mild cognitive impairment and Alzheimer's disease.
Journal of the International Neuropsychological Society : JINS 2008;14(2):222-32.
2008: Barry Reisberg; S Gauthier
Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease.
International psychogeriatrics / IPA 2008;20(1):1-16.
2008: Kevin R Peters; kenneth rockwood; Sandra Black; David B Hogan; S Gauthier; Inge Loy-English; Ging-Yuek R Hsiung; Claudia Jacova; Andrew Kertesz; Howard H Feldman
Neuropsychiatric symptom clusters and functional disability in cognitively-impaired-not-demented individuals.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2008;16(2):136-44.
2008: Luc Letenneur; Karine Pérès; Hervé Fleury; Isabelle Garrigue; Pascale Barberger-Gateau; Catherine Helmer; Jean-Marc Orgogozo; S Gauthier; Jean-François Dartigues
Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study.
PloS one 2008;3(11):e3637.
2008: S Gauthier; Judes Poirier
Current and future management of Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2008;4(1 Suppl 1):S48-50.
2008: S Gauthier
Symptomatic therapeutic aspects in Alzheimer's disease.
Handbook of clinical neurology 2008;89():269-71.
2008: Ging-Yuek R Hsiung; Sina Alipour; Claudia Jacova; Jacob Grand; S Gauthier; Sandra Black; Remi W Bouchard; Andrew Kertesz; Inge Loy-English; David B Hogan; kenneth rockwood; Howard H Feldman
Transition from cognitively impaired not demented to Alzheimer's disease: an analysis of changes in functional abilities in a dementia clinic cohort.
Dementia and geriatric cognitive disorders 2008;25(6):483-90.
2008: Sylvie Belleville; Louis Bherer; Emilie Lepage; Howard Chertkow; S Gauthier
Task switching capacities in persons with Alzheimer's disease and mild cognitive impairment.
Neuropsychologia 2008;46(8):2225-33.
2008: Hao Li; Sally Wetten; Li Li; Pamela L St Jean; Ruchi Upmanyu; Linda Surh; David Hosford; Michael R Barnes; James David Briley; Michael Borrie; Natalie Coletta; Richard Delisle; Daniella Dhalla; Margaret G Ehm; Howard H Feldman; Luis Fornazzari; S Gauthier; Neil Goodgame; Danilo Guzman; Sandra Hammond; Paul Hollingworth; Ging-Yuek Hsiung; Joan Johnson; Devon D Kelly; Ron Keren; Andrew Kertesz; Karen S King; Simon Lovestone; Inge Loy-English; Paul Matthews; Michael J Owen; Mary Plumpton; William Pryse-Phillips; Rab Prinjha; Jill C Richardson; Ann M Saunders; Andrew J Slater; Peter St George-Hyslop; Sandra W Stinnett; Jina Swartz; Rachel L Taylor; John Wherrett; Julie Williams; David P Yarnall; Rachel A Gibson; Michael C Irizarry; Lefkos T Middleton; Allen D Roses
Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease.
Archives of neurology 2008;65(1):45-53.
2007: Bruno Dubois; David J Burn; Christopher G Goetz; Dag Aarsland; Richard Brown; Gerald A Broe; dennis dickson; Charles Duyckaerts; Jeffrey L Cummings; S Gauthier; Amos D Korczyn; Andrew J Lees; Richard Levy; Irene Litvan; Yoshikuni Mizuno; Ian G McKeith; C Warren Olanow; Werner Poewe; Cristina Sampaio; Eduardo Tolosa; Murat Emre
Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force.
Movement disorders : official journal of the Movement Disorder Society 2007;22(16):2314-24.
2007: Nathan Herrmann; S Gauthier; Paul G Lysy
Clinical practice guidelines for severe Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2007;3(4):385-97.
2007: Florian Ferreri; Catherine Agbokou; S Gauthier
[Cardiovascular effects of cholinesterase inhibitors in Alzheimer's disease].
Revue neurologique 2007;163(10):968-74.
2007: Dennis Seow; S Gauthier
Pharmacotherapy of Alzheimer disease.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2007;52(10):620-9.
2007: Murat Emre; Dag Aarsland; Richard Brown; David J Burn; Charles Duyckaerts; Yoshikuni Mizuno; Gerald A Broe; Jeffrey L Cummings; dennis dickson; S Gauthier; Jennifer Goldman; Christopher G Goetz; Amos D Korczyn; Andrew J Lees; Richard Levy; Irene Litvan; Ian G McKeith; Warren Olanow; Werner Poewe; Niall Quinn; Cristina Sampaio; Eduardo Tolosa; Bruno Dubois
Clinical diagnostic criteria for dementia associated with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2007;22(12):1689-707; quiz 1837.
2007: Paul S Aisen; S Gauthier; Bruno Vellas; Richard Briand; Daniel Saumier; Julie Laurin; Denis Garceau
Alzhemed: a potential treatment for Alzheimer's disease.
Current Alzheimer research 2007;4(4):473-8.
2007: Bruno Dubois; Howard H Feldman; Claudia Jacova; Steven T DeKosky; Pascale Barberger-Gateau; Jeffrey L Cummings; André Delacourte; Douglas Galasko; S Gauthier; Gregory A Jicha; Kenichi Meguro; John T O'Brien; Florence Pasquier; Philippe Robert; Martin N Rossor; Steven Salloway; Yaakov Stern; Pieter J Visser; Philip scheltens
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.
Lancet neurology 2007;6(8):734-46.
2007: Alistair Burns; S Gauthier; C Perdomo
Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
International journal of geriatric psychiatry 2007;22(8):806-12.
2007: Bruno Vellas; Sandrine Andrieu; Christelle Cantet; Jean-François Dartigues; S Gauthier
Long-term changes in ADAS-cog: what is clinically relevant for disease modifying trials in Alzheimer?
The journal of nutrition, health & aging 2007;11(4):338-41.
2007: Sylvie Belleville; Howard Chertkow; S Gauthier
Working memory and control of attention in persons with Alzheimer's disease and mild cognitive impairment.
Neuropsychology 2007;21(4):458-69.
2007: S Gauthier; Angela G Juby; B Rehel; R Schecter
EXACT: rivastigmine improves the high prevalence of attention deficits and mood and behaviour symptoms in Alzheimer's disease.
International journal of clinical practice 2007;61(6):886-95.
2007: Richard Camicioli; S Gauthier
Clinical trials in Parkinson's disease dementia and dementia with Lewy bodies.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2007;34 Suppl 1():S109-17.
2007: S Gauthier
Outcomes for assessment of symptomatic and stabilization/disease modifying drugs.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2007;34 Suppl 1():S23-6.
2007: kenneth rockwood; Paige King Moorhouse; Xiaowei Song; Chris MacKnight; S Gauthier; Andrew Kertesz; Patrick Montgomery; Sandra Black; David B Hogan; Antonio Guzman; Remi W Bouchard; Howard Feldman
Disease progression in vascular cognitive impairment: cognitive, functional and behavioural outcomes in the Consortium to Investigate Vascular Impairment of Cognition (CIVIC) cohort study.
Journal of the neurological sciences 2007;252(2):106-12.
2007: Mervin Blair; Andrew Kertesz; N Davis-Faroque; Ging-Yuek R Hsiung; Sandra Black; Remi W Bouchard; S Gauthier; DA Guzman; David B Hogan; kenneth rockwood; Howard Feldman
Behavioural measures in frontotemporal lobar dementia and other dementias: the utility of the frontal behavioural inventory and the neuropsychiatric inventory in a national cohort study.
Dementia and geriatric cognitive disorders 2007;23(6):406-15.
2006: Florian Ferreri; Catherine Agbokou; S Gauthier
Recognition and management of neuropsychiatric complications in Parkinson's disease.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2006;175(12):1545-52.
2006: Jacques Touchon; Florence Portet; S Gauthier
Prevention trials in Alzheimer disease: one step forward?
Neurology 2006;67(9 Suppl 3):S21-2.
2006: Florian Ferreri; Catherine Agbokou; S Gauthier
Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy.
Journal of psychiatry & neuroscience : JPN 2006;31(6):369-76.
2006: S Gauthier; Angela G Juby; Lidia Morelli; Bonita Rehel; Robyn Schecter
A large, naturalistic, community-based study of rivastigmine in mild-to-moderate AD: the EXTEND Study.
Current medical research and opinion 2006;22(11):2251-65.
2006: Jean-François Gagnon; Dominique Petit; Maria Livia Fantini; Sylvie Rompré; S Gauthier; Michel Panisset; Alain Robillard; Jacques Montplaisir
REM sleep behavior disorder and REM sleep without atonia in probable Alzheimer disease.
Sleep 2006;29(10):1321-5.
2006: S Gauthier
Treatment success in Alzheimer's disease.
The journal of nutrition, health & aging 2006;10(5):416.
2006: Carol Hudon; Sylvie Belleville; Céline Souchay; Marie-Christine Gély-Nargeot; Howard Chertkow; S Gauthier
Memory for gist and detail information in Alzheimer's disease and mild cognitive impairment.
Neuropsychology 2006;20(5):566-77.
2006: S Gauthier; Nathan Herrmann; Florian Ferreri; Catherine Agbokou; Catherine Agokou
Use of memantine to treat Alzheimer's disease.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2006;175(5):501-2.
2006: S Gauthier; Bruno Vellas; Martin R Farlow; David J Burn
Aggressive course of disease in dementia.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2006;2(3):210-7.
2006: S Gauthier
Cholinesterase inhibitors in late-stage Alzheimer's disease.
Lancet neurology 2006;5(6):468-9.
2006: S Gauthier; Barry Reisberg; Michael Zaudig; Ronald C. Petersen; Karen Ritchie; Karl Broich; Sylvie Belleville; Henry Brodaty; David A Bennett; Howard Chertkow; Jeffrey L Cummings; Mony J de Leon; Howard Feldman; Mary Ganguli; Harald Hampel; Philip scheltens; Mary C Tierney; Peter J Whitehouse; Bengt Winblad
Mild cognitive impairment.
Lancet 2006;367(9518):1262-70.
2006: Courval Louise de Poulin; Isabelle Gélinas; S Gauthier; David Dayton; Lili Liu; Michel Rossignol; John S Sampalis; Dolly Dastoor
Reliability and validity of the Safety Assessment Scale for people with dementia living at home.
Canadian journal of occupational therapy. Revue canadienne d'ergothérapie 2006;73(2):67-75.
2006: Kevin R Peters; kenneth rockwood; Sandra Black; R Bouchard; S Gauthier; D Hogan; Andrew Kertesz; Inge Loy-English; B L Beattie; A D Sadovnick; Howard H Feldman
Characterizing neuropsychiatric symptoms in subjects referred to dementia clinics.
Neurology 2006;66(4):523-8.
2006: Howard H Feldman; S Gauthier; Howard Chertkow; David K Conn; Morris Freedman; Macknight Chris
Progress in clinical neurosciences: Canadian guidelines for the development of antidementia therapies: a conceptual summary.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2006;33(1):6-26.
2006: kenneth rockwood; Sandra Black; Xiaowei Song; David B Hogan; S Gauthier; Chris MacKnight; Robert A Vandorpe; Antonio Guzman; Patrick Montgomery; Andrew Kertesz; Remi W Bouchard; Howard Feldman
Clinical and radiographic subtypes of vascular cognitive impairment in a clinic-based cohort study.
Journal of the neurological sciences 2006;240(1-2):7-14.
2006: Sylvie Belleville; Brigitte Gilbert; Francine Fontaine; Lise Gagnon; Edith Ménard; S Gauthier
Improvement of episodic memory in persons with mild cognitive impairment and healthy older adults: evidence from a cognitive intervention program.
Dementia and geriatric cognitive disorders 2006;22(5-6):486-99.
2006: Ging-Yuek R Hsiung; Alan Donald; Jacob Grand; Sandra Black; Remi W Bouchard; S Gauthier; Inge Loy-English; David B Hogan; Andrew Kertesz; kenneth rockwood; Howard H Feldman
Outcomes of cognitively impaired not demented at 2 years in the Canadian Cohort Study of Cognitive Impairment and Related Dementias.
Dementia and geriatric cognitive disorders 2006;22(5-6):413-20.
2006: S Gauthier
Managing discontinuation syndrome in patients with dementia.
Journal of psychiatry & neuroscience : JPN 2006;31(1):72.
2005: Ian G McKeith; dennis dickson; J Lowe; M Emre; John T O'Brien; H Feldman; Jeffrey L Cummings; J E Duda; Carol F Lippa; Elaine K Perry; Dag Aarsland; Heii Arai; Clive G Ballard; Bradley Boeve; David J Burn; D Costa; T Del Ser; Bruno Dubois; Douglas Galasko; S Gauthier; Christopher G Goetz; E Gomez-Tortosa; G Halliday; Lawrence A Hansen; John Hardy; Takeshi Iwatsubo; Rajesh N. Kalaria; Daniel Kaufer; R A Kenny; Amos D Korczyn; Kenji Kosaka; Virginia M-Y Lee; Andrew J Lees; I Litvan; E Londos; Oscar L Lopez; Satoshi Minoshima; Yoshikuni Mizuno; J A Molina; E B Mukaetova-Ladinska; Florence Pasquier; Robert H Perry; J B Schulz; John Q Trojanowski; Masahito Yamada
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.
Neurology 2005;65(12):1863-72.
2005: Bruno Vellas; S Gauthier; H Allain; S Andrieu; J-P Aquino; G Berrut; M Berthel; F Blanchard; V Camus; Jean-François Dartigues; Bruno Dubois; F Forette; A Franco; R Gonthier; A Grand; M P Hervy; C Jeandel; M E Joel; P Jouanny; F Lebert; P Michot; Jean-Louis Montastruc; F Nourhashemi; P J Ousset; J Pariente; A S Rigaud; P Robert; G Ruault; D Strubel; J Touchon; M Verny; J M Vetel
[Consensus statement on severe dementia].
Presse médicale (Paris, France : 1983) 2005;34(20 Pt 1):1545-55.
2005: S Gauthier
Alzheimer's disease: the benefits of early treatment.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2005;12 Suppl 3():11-6.
2005: S Gauthier
Realizing early treatment benefits in dementia.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2005;12 Suppl 3():1-2.
2005: Bruno Vellas; S Gauthier; H Allain; S Andrieu; J-P Aquino; G Berrut; M Berthel; F Blanchard; V Camus; Jean-François Dartigues; Bruno Dubois; F Forette; A Franco; R Gonthier; A Grand; M-P Hervy; C Jeandel; M-E Joel; P Jouanny; F Lebert; P Michot; Jean-Louis Montastruc; F Nourhashemi; P-J Ousset; J Pariente; A-S Rigaud; P Robert; G Ruault; D Strubel; J Touchon; M Verny; J-M Vetel
[Consensus statement on severe dementia].
Revue neurologique 2005;161(8-9):868-77.
2005: Bruno Vellas; S Gauthier; H Allain; S Andrieu; J P Aquino; G Berrut; M Berthel; F Blanchard; V Camus; Jean-François Dartigues; Bruno Dubois; F Forette; A Franco; R Gonthier; A Grand; M P Hervy; C Jeandel; M E Joel; P Jouanny; F Lebert; P Michot; Jean-Louis Montastruc; F Nourhashemi; P J Ousset; J Pariente; A S Rigaud; P Robert; G Ruault; D Strubel; J Touchon; M Verny; J M Vetel
Consensus statement on dementia of Alzheimer type in the severe stage.
The journal of nutrition, health & aging 2005;9(5):330-8.
2005: S Gauthier; Jacques Touchon
Mild cognitive impairment is not a clinical entity and should not be treated.
Archives of neurology 2005;62(7):1164-6; discussion 1167.
2005: Howard Feldman; S Gauthier; Jane Hecker; Bruno Vellas; Yikang Xu; John R Ieni; Elias M Schwam
Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
International journal of geriatric psychiatry 2005;20(6):559-69.
2005: S Gauthier; Yvonne Wirth; Hans Jörg Möbius
Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies.
International journal of geriatric psychiatry 2005;20(5):459-64.
2005: S Gauthier
Drugs for Alzheimer's disease and related dementias.
BMJ (Clinical research ed.) 2005;330(7496):857-8.
2005: Nadeem H Bhanji; S Gauthier
Emergent complications following donepezil switchover to galantamine in three cases of dementia with Lewy bodies.
The Journal of neuropsychiatry and clinical neurosciences 2005;17(4):552-5.
2004: Timo Erkinjuntti; Gustavo Román; S Gauthier
Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors.
Journal of the neurological sciences 2004;226(1-2):63-6.
2004: S Gauthier
The benefits of apolipoprotein E epsilon4 screening to research.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2004;171(8):881.
2004: Howard Feldman; S Gauthier; Jane Hecker; Bruno Vellas; Margaret Hux; Y Xu; Elias M Schwam; S Shah; Vera Mastey
Economic evaluation of donepezil in moderate to severe Alzheimer disease.
Neurology 2004;63(4):644-50.
2004: Timo Erkinjuntti; Gustavo Román; S Gauthier
Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors.
Neurological research 2004;26(5):603-5.
2004: Timo Erkinjuntti; Gustavo Román; S Gauthier; Howard Feldman; kenneth rockwood
Emerging therapies for vascular dementia and vascular cognitive impairment.
Stroke; a journal of cerebral circulation 2004;35(4):1010-7.
2004: Sophie Blanchet; Sylvie Belleville; N Phillips; S Mellah; S Gauthier; Howard Chertkow
Electrophysiological study of working memory in mild cognitive impairment patients.
Brain and cognition 2004;54(2):144-5.
2004: S Gauthier
[Treatment of Alzheimer's disease: general methodological aspects].
Revue neurologique 2004;160(2):261-4.
2004: Michael Grundman; Ronald C. Petersen; Steven H Ferris; Ronald Thomas; Paul S Aisen; David A Bennett; Norman L Foster; Clifford R Jack; Douglas Galasko; Rachelle S Doody; Jeffrey A Kaye; Mary Sano; Richard C Mohs; S Gauthier; Hyun T Kim; Shelia Jin; Arlan N Schultz; Kimberly Schafer; Ruth Mulnard; Christopher H van Dyck; Jacobo E Mintzer; Edward Zamrini; Deborah A Cahn-Weiner; Leon J Thal
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.
Archives of neurology 2004;61(1):59-66.
2004: Ian G McKeith; Jacobo E Mintzer; Dag Aarsland; David J Burn; Helen Chiu; Jiska Cohen-Mansfield; dennis dickson; Bruno Dubois; John E Duda; Howard Feldman; S Gauthier; Glenda Halliday; Brian A Lawlor; Carol F Lippa; Oscar L Lopez; João Carlos Machado; John T O'Brien; Jeremy Playfer; Wayne Reid
Dementia with Lewy bodies.
Lancet neurology 2004;3(1):19-28.
2003: Howard Feldman; Adrian R Levy; Ging-Yuek R Hsiung; Kevin R Peters; A Donald; Sandra Black; Remi W Bouchard; S Gauthier; DA Guzman; David B Hogan; Andrew Kertesz; kenneth rockwood
A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results.
Neuroepidemiology 2003;22(5):265-74.
2003: Richard R Desrosiers; Yanick Bertrand; Quynh-Tran Nguyen; Michel Demeule; Reinhard Gabathuler; Malcolm Kennard; S Gauthier; Richard Béliveau
Expression of melanotransferrin isoforms in human serum: relevance to Alzheimer's disease.
The Biochemical journal 2003;374(Pt 2):463-71.
2003: kenneth rockwood; Heather Davis; Chris MacKnight; Robert A Vandorpe; S Gauthier; Antonio Guzman; Patrick Montgomery; Sandra Black; David B Hogan; Andrew Kertesz; Remi W Bouchard; Howard Feldman
The Consortium to Investigate Vascular Impairment of Cognition: methods and first findings.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2003;30(3):237-43.
2003: Hervé Allain; Danièle Bentué-Ferrer; Olivier Tribut; S Gauthier; Bernard-François Michel; Christophe Drieu-La Rochelle
Alzheimer's disease: the pharmacological pathway.
Fundamental & clinical pharmacology 2003;17(4):419-28.
2003: Jan Marcusson; Roger Bullock; S Gauthier; Alexander Kurz; Susanne Schwalen
Galantamine demonstrates efficacy and safety in elderly patients with Alzheimer disease.
Alzheimer disease and associated disorders 2003;17 Suppl 3():S86-91.
2003: Howard Feldman; S Gauthier; Jane Hecker; Bruno Vellas; Birol Emir; Vera Mastey; Ponni Subbiah
Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden.
Journal of the American Geriatrics Society 2003;51(6):737-44.
2003: John T O'Brien; Timo Erkinjuntti; Barry Reisberg; Gustavo Roman; Tohru Sawada; Leonardo Pantoni; John V Bowler; Clive G Ballard; Charles DeCarli; Philip B Gorelick; kenneth rockwood; Alistair Burns; S Gauthier; Steven T DeKosky
Vascular cognitive impairment.
Lancet neurology 2003;2(2):89-98.
2003: S Gauthier; kenneth rockwood
Does vascular MCI progress at a different rate than does amnestic MCI?
International psychogeriatrics / IPA 2003;15 Suppl 1():257-9.
2003: S Gauthier; Murat Emre; Martin R Farlow; Roger Bullock; George T Grossberg; Steven G Potkin
Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors.
Current medical research and opinion 2003;19(8):707-14.
2003: A Law; S Gauthier; R Quirion
Alteration of nitric oxide synthase activity in young and aged apolipoprotein E-deficient mice.
Neurobiology of aging 2003;24(1):187-90.
2002: S Gauthier; Howard Feldman; Jane Hecker; Bruno Vellas; David Ames; Ponni Subbiah; Edward Whalen; Birol Emir
Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease.
International psychogeriatrics / IPA 2002;14(4):389-404.
2002: M Panisset; S Gauthier; Herbert Moessler; Manfred Windisch
Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(7-8):1089-104.
2002: S Gauthier
Current and future therapeutic strategies for Alzheimer's disease and related dementias.
Expert review of neurotherapeutics 2002;2(3):277-8.
2002: Timo Erkinjuntti; Alexander Kurz; S Gauthier; Roger Bullock; Sean Lilienfeld; ChandrasekharRao Venkata Damaraju
Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial.
Lancet 2002;359(9314):1283-90.
2002: S Gauthier
Advances in the pharmacotherapy of Alzheimer's disease.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2002;166(5):616-23.
2002: S Gauthier; Howard Feldman; Jane Hecker; Bruno Vellas; Birol Emir; Ponni Subbiah
Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease.
Current medical research and opinion 2002;18(6):347-54.
2002: A Law; J O'Donnell; S Gauthier; R Quirion
Neuronal and inducible nitric oxide synthase expressions and activities in the hippocampi and cortices of young adult, aged cognitively unimpaired, and impaired Long-Evans rats.
Neuroscience 2002;112(2):267-75.
2002: Aaron K Sibley; Chris MacKnight; kenneth rockwood; John D Fisk; S Gauthier; DA Guzman; David B Hogan
The effect of the living situation on the severity of dementia at diagnosis.
Dementia and geriatric cognitive disorders 2002;13(1):40-5.
2001: Carolyn Wentzel; kenneth rockwood; Chris MacKnight; vladimir hachinski; David B Hogan; Howard Feldman; Truls Østbye; Christina Wolfson; S Gauthier; René Verreault; Ian McDowell
Progression of impairment in patients with vascular cognitive impairment without dementia.
Neurology 2001;57(4):714-6.
2001: Howard Feldman; S Gauthier; Jane Hecker; Bruno Vellas; Ponni Subbiah; E Whalen
A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease.
Neurology 2001;57(4):613-20.
2001: A Law; S Gauthier; R Quirion
Neuroprotective and neurorescuing effects of isoform-specific nitric oxide synthase inhibitors, nitric oxide scavenger, and antioxidant against beta-amyloid toxicity.
British journal of pharmacology 2001;133(7):1114-24.
2001: Bengt Winblad; H Brodaty; S Gauthier; John C Morris; J M Orgogozo; kenneth rockwood; Lon S Schneider; Masatoshi Takeda; Pierre N. Tariot; D Wilkinson
Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?
International journal of geriatric psychiatry 2001;16(7):653-66.
2001: S Gauthier; S Ferris
Outcome measures for probable vascular dementia and Alzheimer's disease with cerebrovascular disease.
International journal of clinical practice. Supplement 2001;(120):29-39.
2001: Howard Feldman; A Sauter; A Donald; I Gélinas; S Gauthier; K Torfs; W Parys; A Mehnert
The disability assessment for dementia scale: a 12-month study of functional ability in mild to moderate severity Alzheimer disease.
Alzheimer disease and associated disorders 2001;15(2):89-95.
2001: A Law; S Gauthier; R Quirion
Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type.
Brain research. Brain research reviews 2001;35(1):73-96.
2001: Christopher Patterson; S Gauthier; Howard Bergman; C Cohen; John W Feightner; H Feldman; A Grek; David B Hogan
The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2001;28 Suppl 1():S3-16.
2001: Howard Chertkow; H Bergman; Hyman M Schipper; S Gauthier; R Bouchard; S Fontaine; A Mark Clarfield
Assessment of suspected dementia.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2001;28 Suppl 1():S28-41.
2001: C Patterson; S Gauthier
Canadian consensus conference on dementia: two years later.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2001;28 Suppl 1():S1-2.
2001: S Gauthier
Cholinergic adverse effects of cholinesterase inhibitors in Alzheimer's disease: epidemiology and management.
Drugs & aging 2001;18(11):853-62.
2001: S Gauthier
Alzheimer's disease: current and future therapeutic perspectives.
Progress in neuro-psychopharmacology & biological psychiatry 2001;25(1):73-89.
2000: J F Baladi; P A Bailey; Sandra Black; R W Bouchard; K D Farcnik; S Gauthier; A Kertesz; E Mohr; A Robillard
Rivastigmine for Alzheimer's disease: Canadian interpretation of intermediate outcome measures and cost implications.
Clinical therapeutics 2000;22(12):1549-61.
2000: S Gauthier
Should we encourage the use of high-dose vitamin E in persons with memory complaints as a preventive strategy against Alzheimer's disease?
Journal of psychiatry & neuroscience : JPN 2000;25(4):394.
2000: kenneth rockwood; Chris MacKnight; Carolyn Wentzel; Sandra Black; Remi W Bouchard; S Gauthier; Howard Feldman; D Hogan; Andrew Kertesz; Patrick Montgomery
The diagnosis of "mixed" dementia in the Consortium for the Investigation of Vascular Impairment of Cognition (CIVIC).
Annals of the New York Academy of Sciences 2000;903():522-8.
2000: A Law; Sylvain Dore; Seth Blackshaw; S Gauthier; Rémi Quirion
Alteration of expression levels of neuronal nitric oxide synthase and haem oxygenase-2 messenger RNA in the hippocampi and cortices of young adult and aged cognitively unimpaired and impaired Long-Evans rats.
Neuroscience 2000;100(4):769-75.
2000: Isabelle Gélinas; S Gauthier; P A Cyrus
Metrifonate enhances the ability of Alzheimer's disease patients to initiate, organize, and execute instrumental and basic activities of daily living.
Journal of geriatric psychiatry and neurology 2000;13(1):9-16.
1999: S Gauthier; kenneth rockwood; I Gélinas; L Sykes; S Teunisse; JM Orgogozo; Timo Erkinjuntti; H Erzigkeit; M Gleeson; B Kittner; M Pontecorvo; H Feldman; Peter J Whitehouse
Outcome measures for the study of activities of daily living in vascular dementia.
Alzheimer disease and associated disorders 1999;13 Suppl 3():S143-7.
1999: Isabelle Gélinas; L Gauthier; M McIntyre; S Gauthier
Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia.
The American journal of occupational therapy : official publication of the American Occupational Therapy Association 1999;53(5):471-81.
1999: AM Issa; S Gauthier; B Collier
Enzyme activity and protein of multiple forms of choline acetyltransferase: effects of calyculin A and okadaic acid.
Neurochemical research 1999;24(8):987-93.
1999: Peter J Whitehouse; Raul Arizaga; H Brodaty; S Gauthier; N Graham; R C Green; A Homma; C Mangone; V Senanarong; X H Xu
Placebos in clinical trials in Alzheimer disease: an international discussion.
Alzheimer disease and associated disorders 1999;13(3):121-3.
1999: Christopher J Patterson; S Gauthier; Howard Bergman; C A Cohen; John W Feightner; H Feldman; David B Hogan
The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1999;160(12 Suppl):S1-15.
1999: Christopher J Patterson; S Gauthier; Howard Bergman; C A Cohen; John W Feightner; H Feldman; David B Hogan
Canadian Consensus Conference on Dementia: a physician's guide to using the recommendations.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1999;160(12):1738-42.
1999: S Gauthier
Do we have a treatment for Alzheimer disease? Yes.
Archives of neurology 1999;56(6):738-9.
1999: SS Jung; S Gauthier; Neil R Cashman
Beta-amyloid precursor protein is detectable on monocytes and is increased in Alzheimer's disease.
Neurobiology of aging 1999;20(3):249-57.
1999: T Mendis; O Suchowersky; Anthony E Lang; S Gauthier
Management of Parkinson's disease a review of current and new therapies.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1999;26(2):89-103.
1999: Alistair Burns; Martin N Rossor; J Hecker; S Gauthier; H Petit; Hans-Jürgen Möller; SL Rogers; Lawrence Friedhofff
The effects of donepezil in Alzheimer's disease - results from a multinational trial.
Dementia and geriatric cognitive disorders 1999;10(3):237-44.
1999: Bernie J O'Brien; Ron Goeree; Margaret Hux; Michael Iskedjian; Gordon Blackhouse; Micheline Gagnon; S Gauthier
Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada.
Journal of the American Geriatrics Society 1999;47(5):570-8.
1999: H Brodaty; R Dresser; M Eisner; T Erkunjuntti; S Gauthier; N Graham; C Jonker; Greg A. Sachs; Peter J Whitehouse
Alzheimer's Disease International and International Working Group for Harmonization of Dementia Drug Guidelines for research involving human subjects with dementia.
Alzheimer disease and associated disorders 1999;13(2):71-9.
1999: Carole A Cohen; Peter J Whitehouse; Stephen G Post; S Gauthier; A Eberhart; L LeDuc
Ethical issues in Alzheimer disease: the experience of a national Alzheimer society task force.
Alzheimer disease and associated disorders 1999;13(2):66-70.
1999: M Rösler; R Anand; A Cicin-Sain; S Gauthier; Yves Agid; P Dal-Bianco; H B Stähelin; R Hartman; M Gharabawi
Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial.
BMJ (Clinical research ed.) 1999;318(7184):633-8.
1999: AM Issa; S Gauthier; B Collier
Effects of calyculin A and okadaic acid on acetylcholine release and subcellular distribution in rat hippocampal formation.
Journal of neurochemistry 1999;72(1):166-73.
1999: S Gauthier
Managing expectations in the long-term treatment of Alzheimer's disease.
Gerontology 1999;45 Suppl 1():33-8.
1998: Peter J Whitehouse; Bengt Winblad; D Shostak; A Bhattacharjya; M Brod; H Brodaty; Avi Dor; Howard Feldman; F Forette; S Gauthier; J Hay; C Henke; S Hill; Vera Mastey; P Neumann; B O'Brien; K Pugner; Mary Sano; T Sawada; R Stone; Anders Wimo
First International Pharmacoeconomic Conference on Alzheimer's Disease: report and summary.
Alzheimer disease and associated disorders 1998;12(4):266-80.
1998: S Gauthier
Clinical trials and therapy.
Current opinion in neurology 1998;11(5):435-8.
1998: Margaret Hux; Bernie J O'Brien; Michael Iskedjian; Ron Goeree; Micheline Gagnon; S Gauthier
Relation between severity of Alzheimer's disease and costs of caring.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1998;159(5):457-65.
1998: John D Fisk; A D Sadovnick; Carole A Cohen; S Gauthier; J Dossetor; A Eberhart; L LeDuc
Ethical guidelines of the Alzheimer Society of Canada.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1998;25(3):242-8.
1998: Y Lakmache; Maryse Lassonde; S Gauthier; J Y Frigon; Franco Lepore
Interhemispheric disconnection syndrome in Alzheimer's disease.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(15):9042-6.
1998: S Gauthier
Prevention of Alzheimer's disease.
Annales de médecine interne 1998;149(4):228-30.
1998: Uwe Beffert; P Bertrand; D Champagne; S Gauthier; J Poirier
HSV-1 in brain and risk of Alzheimer's disease.
Lancet 1998;351(9112):1330-1.
1998: Jacques Montplaisir; Dominique Petit; S Gauthier; H Gaudreau; Anne Décary
Sleep disturbances and eeg slowing in alzheimer's disease.
Sleep research online : SRO 1998;1(4):147-51.
1998: S Gauthier
Update on diagnostic methods, natural history and outcome variables in Alzheimer's disease.
Dementia and geriatric cognitive disorders 1998;9 Suppl 3():2-7.
1998: S Gauthier; Michel Panisset
Current diagnostic methods and outcome variables for clinical investigation of Alzheimer's disease.
Journal of neural transmission. Supplementum 1998;53():251-4.
1997: Christian Duval; Anne Beuter; S Gauthier
Fluctuations in tremor at rest and saccadic eye movements in subjects with Parkinsons disease.
Parkinsonism & related disorders 1997;3(4):195-205.
1997: Mona Baumgarten; R N Battista; C Infante-Rivard; J A Hanley; R Becker; Warren B Bilker; S Gauthier
Use of physician services among family caregivers of elderly persons with dementia.
Journal of clinical epidemiology 1997;50(11):1265-72.
1997: S Gauthier; Michel Panisset; J Nalbantoglu; J Poirier
Alzheimer's disease: current knowledge, management and research.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1997;157(8):1047-52.
1997: Jacques Montplaisir; Dominique Petit; Anne Décary; Hélène Masson; Marc-André Bédard; Michel Panisset; Guy M Rémillard; S Gauthier
Sleep and quantitative EEG in patients with progressive supranuclear palsy.
Neurology 1997;49(4):999-1003.
1997: Gregory Govoni; S Gauthier; Filio Billia; Norman N Iscove; Philippe Gros
Cell-specific and inducible Nramp1 gene expression in mouse macrophages in vitro and in vivo.
Journal of leukocyte biology 1997;62(2):277-86.
1997: Janice E Graham; kenneth rockwood; B L Beattie; R Eastwood; S Gauthier; Holly A Tuokko; Ian McDowell
Prevalence and severity of cognitive impairment with and without dementia in an elderly population.
Lancet 1997;349(9068):1793-6.
1997: kenneth rockwood; B L Beattie; M R Eastwood; Howard Feldman; E Mohr; W Pryse-Phillips; S Gauthier
A randomized, controlled trial of linopirdine in the treatment of Alzheimer's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1997;24(2):140-5.
1997: Neil Bodick; Walter W Offen; Allan Levey; Neal R Cutler; S Gauthier; Andrew Satlin; Harlan E Shannon; Gary D Tollefson; Kurt Rasmussen; Frank P Bymaster; D J Hurley; W Z Potter; S M Paul
Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease.
Archives of neurology 1997;54(4):465-73.
1997: Paulo Caramelli; A Poissant; S Gauthier; A Bellavance; D Gauvreau; André Roch Lecours; Yves Joanette
Educational level and neuropsychological heterogeneity in dementia of the Alzheimer type.
Alzheimer disease and associated disorders 1997;11(1):9-15.
1997: S Gauthier; Isabelle Gélinas; L Gauthier
Functional disability in Alzheimer's disease.
International psychogeriatrics / IPA 1997;9 Suppl 1():163-5.
1997: Peter J Whitehouse; JM Orgogozo; R E Becker; S Gauthier; M Pontecorvo; H Erzigkeit; S Rogers; Richard C Mohs; N Bodick; G Bruno; P Dal-Bianco
Quality-of-life assessment in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer disease and associated disorders 1997;11 Suppl 3():56-60.
1997: Stephen G Post; B Beerman; H Brodaty; A W Gaines; S Gauthier; Geldmacher David; S Hill; A Homma; Martin N Rossor; Peter J Whitehouse; Bengt Winblad
Ethical issues in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer disease and associated disorders 1997;11 Suppl 3():26-8.
1997: S Gauthier; N Bodick; E Erzigkeit; H Feldman; Geldmacher David; J Huff; Richard C Mohs; JM Orgogozo; S Rogers
Activities of daily living as an outcome measure in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer disease and associated disorders 1997;11 Suppl 3():6-7.
1997: F Hassainia; D Petit; T Nielsen; S Gauthier; J Montplaisir
Quantitative EEG and statistical mapping of wakefulness and REM sleep in the evaluation of mild to moderate Alzheimer's disease.
European neurology 1997;37(4):219-24.
1997: C Pallister; SS Jung; I Shaw; Josephine Nalbantoglu; S Gauthier; Neil R Cashman
Lymphocyte content of amyloid precursor protein is increased in Down's syndrome and aging.
Neurobiology of aging 1997;18(1):97-103.
1996: S M Vidal; E Pinner; P Lepage; S Gauthier; P Gros
Natural resistance to intracellular infections: Nramp1 encodes a membrane phosphoglycoprotein absent in macrophages from susceptible (Nramp1 D169) mouse strains.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(8):3559-68.
1996: L Poulin de Courval; A Saroyan; L Joseph; S Gauthier
[The competence of family physicians in caring for dementia patients. A survey of general practitioners in Quebec].
Canadian family physician Médecin de famille canadien 1996;42():1496-502.
1996: Isabelle Aubert; D Cécyre; S Gauthier; Rémi Quirion
Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain.
The Journal of comparative neurology 1996;369(1):31-55.
1996: AM Issa; S Gauthier; B Collier
Effects of the phosphatase inhibitors calyculin A and okadaic acid on acetylcholine synthesis and content of rat hippocampal formation.
Journal of neurochemistry 1996;66(5):1924-32.
1996: S Gauthier; Mona Baumgarten; R Becker
Dementia Behavior Disturbance Scale.
International psychogeriatrics / IPA 1996;8 Suppl 3():325-7.
1996: Janice E Graham; kenneth rockwood; B L Beattie; I McDowell; R Eastwood; S Gauthier
Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging.
Neuroepidemiology 1996;15(5):246-56.
1996: S Gauthier; J Montplaisir; D Petit; Y Joanette; H Feldman; E Mohr; N P Nair; J Poirier
Outcome variables in presymptomatic individuals at higher risk of developing Alzheimer disease.
Alzheimer disease and associated disorders 1996;10 Suppl 1():19-21.
1996: J Montplaisir; Dominique Petit; D McNamara; S Gauthier
Comparisons between SPECT and quantitative EEG measures of cortical impairment in mild to moderate Alzheimer's disease.
European neurology 1996;36(4):197-200.
1995: Judes Poirier; M C Delisle; Rémi Quirion; Isabelle Aubert; Martin R Farlow; Debomoy K Lahiri; Siu Hui; P Bertrand; J Nalbantoglu; Brian M Gilfix; S Gauthier
Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(26):12260-4.
1995: Isabelle Aubert; WB Rowe; Michael J Meaney; S Gauthier; Rémi Quirion
Cholinergic markers in aged cognitively impaired Long-Evans rats.
Neuroscience 1995;67(2):277-92.
1995: S Ledoux; C Bergeron; J Nalbantoglu; S Gauthier; N R Cashman
Polymerase chain reaction quantification of lymphoid amyloid precursor protein mRNAs in Alzheimer's disease and Down's syndrome.
Neuroscience letters 1995;193(2):137-9.
1995: Michael P McDermott; Joseph Jankovic; Julie H Carter; Stanley Fahn; S Gauthier; Christopher G Goetz; Lawrence I Golbe; William Koller; Anthony E Lang; C Warren Olanow
Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group.
Archives of neurology 1995;52(6):565-70.
1995: J Montplaisir; Dominique Petit; D Lorrain; S Gauthier; T Nielsen
Sleep in Alzheimer's disease: further considerations on the role of brainstem and forebrain cholinergic populations in sleep-wake mechanisms.
Sleep 1995;18(3):145-8.
1995: E Mohr; H Feldman; S Gauthier
Canadian guidelines for the development of antidementia therapies: a conceptual summary.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1995;22(1):62-71.
1995: Edward W Keyserlingk; Kathleen Glass; Sandra Kogan; S Gauthier
Proposed guidelines for the participation of persons with dementia as research subjects.
Perspectives in biology and medicine 1995;38(2):319-61.
1995: Henry Brodaty; M Conneally; S Gauthier; C Jennings; A Lennox; Simon Lovestone
Consensus statement on predictive testing for Alzheimer disease.
Alzheimer disease and associated disorders 1995;9(4):182-7.
1994: J Nalbantoglu; Brian M Gilfix; P Bertrand; Y Robitaille; S Gauthier; D S Rosenblatt; Judes Poirier
Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies.
Annals of neurology 1994;36(6):889-95.
1994: S Vida; P Des Rosiers; L Carrier; S Gauthier
Prevalence of depression in Alzheimer's disease and validity of Research Diagnostic Criteria.
Journal of geriatric psychiatry and neurology 1994;7(4):238-44.
1994: S Vida; P Des Rosiers; L Carrier; S Gauthier
Depression in Alzheimer's disease: receiver operating characteristic analysis of the Cornell Scale for Depression in Dementia and the Hamilton Depression Scale.
Journal of geriatric psychiatry and neurology 1994;7(3):159-62.
1994: Isabelle Aubert; Judes Poirier; S Gauthier; Rémi Quirion
Multiple cholinergic markers are unexpectedly not altered in the rat dentate gyrus following entorhinal cortex lesions.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1994;14(5 Pt 1):2476-84.
1994: Marzia Baldereschi; Maria Pia Amato; P Nencini; Giovanni Pracucci; A Lippi; Luigi Amaducci; S Gauthier; L Beatty; P Quiroga; G Klassen
Cross-national interrater agreement on the clinical diagnostic criteria for dementia. WHO-PRA Age-Associated Dementia Working Group, WHO-Program for Research on Aging, Health of Elderly Program.
Neurology 1994;44(2):239-42.
1994: Mona Baumgarten; J A Hanley; Claire Infante-Rivard; R N Battista; R Becker; S Gauthier
Health of family members caring for elderly persons with dementia. A longitudinal study.
Annals of internal medicine 1994;120(2):126-32.
1994: M F Reis; D P Gold; D Andres; D Markiewicz; S Gauthier
Personality traits as determinants of burden and health complaints in caregiving.
International journal of aging & human development 1994;39(3):257-71.
1994: Anne Beuter; Donna Mergler; A de Geoffroy; L Carrière; S Bélanger; L Varghese; J Sreekumar; S Gauthier
Diadochokinesimetry: a study of patients with Parkinson's disease and manganese exposed workers.
Neurotoxicology 1994;15(3):655-64.
1993: J Poirier; J Davignon; D Bouthillier; S Kogan; P Bertrand; S Gauthier
Apolipoprotein E polymorphism and Alzheimer's disease.
Lancet 1993;342(8873):697-9.
1993: J Poirier; A Baccichet; D Dea; S Gauthier
Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats.
Neuroscience 1993;55(1):81-90.
1993: Dominique Petit; J Montplaisir; D Lorrain; S Gauthier
THA does not affect sleep or EEG spectral power in Alzheimer's disease.
Biological psychiatry 1993;33(10):753-4.
1993: Dominique Petit; D Lorrain; S Gauthier; J Montplaisir
Regional spectral analysis of the REM sleep EEG in mild to moderate Alzheimer's disease.
Neurobiology of aging 1993;14(2):141-5.
1993: S Gauthier; L Gauthier
What have we learned from the THA trials to facilitate testing of new AChE inhibitors.
Progress in brain research 1993;98():427-9.
1992: J Poirier; D Dea; A Baccichet; S Gauthier
Modulation of gamma-actin and alpha 1-tubulin expression by corticosterone during neuronal plasticity in the hippocampus.
Brain research. Molecular brain research 1992;15(3-4):263-8.
1992: NP Dooley; S Gauthier; Heather D Durham
Antibody to beta-amyloid precursor protein recognizes an intermediate filament-associated protein in Alzheimer's and control fibroblasts.
Journal of neuroscience research 1992;33(1):60-7.
1992: Dominique Petit; J Montplaisir; D Lorrain; S Gauthier
Spectral analysis of the rapid eye movement sleep electroencephalogram in right and left temporal regions: a biological marker of Alzheimer's disease.
Annals of neurology 1992;32(2):172-6.
1992: Isabelle Aubert; D Cécyre; S Gauthier; Rémi Quirion
Characterization and autoradiographic distribution of [3H]AF-DX 384 binding to putative muscarinic M2 receptors in the rat brain.
European journal of pharmacology 1992;217(2-3):173-84.
1992: Isabelle Aubert; D M Araujo; D Cécyre; Yvonne Robitaille; S Gauthier; Rémi Quirion
Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases.
Journal of neurochemistry 1992;58(2):529-41.
1992: S Gauthier; D Amyot
Sustained release antiparkinson agents: controlled release levodopa.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1992;19(1 Suppl):153-5.
1992: Anne Beuter; L Carrière; B McFadyen; S Gauthier
The organization of stepping in patients with Parkinson's disease: bradykinesia or discoordination?
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1992;19(1):8-16.
1992: Mona Baumgarten; R N Battista; Claire Infante-Rivard; J A Hanley; R Becker; S Gauthier
The psychological and physical health of family members caring for an elderly person with dementia.
Journal of clinical epidemiology 1992;45(1):61-70.
1991: S Gauthier; L Gauthier; R Bouchard; R Quirion; S Sultan
Treatment of Alzheimer's disease: hopes and reality.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1991;18(3 Suppl):439-41.
1991: J E Stewart; Hugues Barbeau; S Gauthier
Modulation of locomotor patterns and spasticity with clonidine in spinal cord injured patients.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1991;18(3):321-32.
1991: S Gauthier
[Parkinson disease: to investigate as soon as possible. Interview by Robert Henry].
L'unión médicale du Canada 1991;120(2):91-6.
1991: J Poirier; S Kogan; S Gauthier
Environment, genetics and idiopathic Parkinson's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1991;18(1):70-6.
1991: L Liu; L Gauthier; S Gauthier
Spatial disorientation in persons with early senile dementia of the Alzheimer type.
The American journal of occupational therapy : official publication of the American Occupational Therapy Association 1991;45(1):67-74.
1990: S Gauthier; I McDowell; G Hill
Canadian Study of Health and Aging (CaSHA).
Psychiatric journal of the University of Ottawa : Revue de psychiatrie de l'Université d'Ottawa 1990;15(4):227-9.
1990: Anne Beuter; John G Milton; C Labrie; L Glass; S Gauthier
Delayed visual feedback and movement control in Parkinson's disease.
Experimental neurology 1990;110(2):228-35.
1990: Joseph Jankovic; M McDermott; Julie H Carter; S Gauthier; Christopher G Goetz; Lawrence I Golbe; S Huber; William Koller; C Warren Olanow; Ira Shoulson
Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group.
Neurology 1990;40(10):1529-34.
1990: A M Issa; WB Rowe; S Gauthier; Michael J Meaney
Hypothalamic-pituitary-adrenal activity in aged, cognitively impaired and cognitively unimpaired rats.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1990;10(10):3247-54.
1990: M Wainberg; Hugues Barbeau; S Gauthier
The effects of cyproheptadine on locomotion and on spasticity in patients with spinal cord injuries.
Journal of neurology, neurosurgery, and psychiatry 1990;53(9):754-63.
1990: G Lacoste-Royal; M Mathieu; J Nalbantoglu; J P Julien; S Gauthier; D Gauvreau
Lack of association between two restriction fragment length polymorphisms in the genes for the light and heavy neurofilament proteins and Alzheimer's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1990;17(3):302-5.
1990: S Gauthier; R Bouchard; A Lamontagne; P Bailey; Howard Bergman; J Ratner; Y Tesfaye; M Saint-Martin; Y Bacher; L Carrier
Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.
The New England journal of medicine 1990;322(18):1272-6.
1990: Mona Baumgarten; R Becker; S Gauthier
Validity and reliability of the dementia behavior disturbance scale.
Journal of the American Geriatrics Society 1990;38(3):221-6.
1990: S Lal; S Gauthier; P L Wood; M E Kiely; J Waserman; N P Vasavan Nair
Red cell choline in spasmodic torticollis and in a monozygotic twin pair with Tourette's syndrome.
Progress in neuro-psychopharmacology & biological psychiatry 1990;14(5):785-9.
1990: L Gauthier; S Gauthier
Assessment of functional changes in Alzheimer's disease.
Neuroepidemiology 1990;9(4):183-8.
1990: Rémi Quirion; Isabelle Aubert; Yvonne Robitaille; S Gauthier; D M Araujo; Jean-Guy Chabot
Neurochemical deficits in pathological brain aging: specificity and possible relevance for treatment strategies.
Clinical neuropharmacology 1990;13 Suppl 3():S73-80.
1989: Rémi Quirion; Isabelle Aubert; P A Lapchak; R P Schaum; S Teolis; S Gauthier; D M Araujo
Muscarinic receptor subtypes in human neurodegenerative disorders: focus on Alzheimer's disease.
Trends in pharmacological sciences 1989;Suppl():80-4.
1989: S Gauthier; R Bouchard; Y Bacher; P Bailey; Howard Bergman; L Carrier; R Charbonneau; M Clarfield; B Collier; D Dastoor
Progress report on the Canadian Multicentre Trial of tetrahydroaminoacridine with lecithin in Alzheimer's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1989;16(4 Suppl):543-6.
1989: D Gautrin; J Nalbantoglu; G Lacoste-Royal; M Grenon; S Gauthier; R Bouchard; J Mathieu; Yvonne Robitaille; L P Doyon; H Bergman
Ascertainment of informative Alzheimer disease families from the IMAGE Project registry for genetic linkage analysis studies.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1989;16(4 Suppl):468-72.
1989: Denyse Gautrin; S Gauthier
Alzheimer's disease: environmental factors and etiologic hypotheses.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1989;16(4):375-87.
1989: K Yashpal; S Gauthier; J L Henry
Thyrotropin-releasing hormone given intrathecally to the rat increases arterial pressure and heart rate.
Circulation research 1989;65(4):859-68.
1989: Kiran Yashpal; S Gauthier; James L Henry
Angiotensin II stimulates sympathetic output by a direct spinal action.
Neuropeptides 1989;14(1):21-9.
1989: S Lal; N P V Nair; J X Thavundayil; V Tawar; Y Tesfaye; D Dastoor; S Gauthier; H Guyda
Growth hormone response to apomorphine, a dopamine receptor agonist, in normal aging and in dementia of the Alzheimer type.
Neurobiology of aging 1989;10(3):227-31.
1989: S Vida; L Gauthier; S Gauthier
Canadian collaborative study of tetrahydroaminoacridine (THA) and lecithin treatment of Alzheimer's disease: effect on mood.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 1989;34(3):165-70.
1988: J Metuzals; Y Robitaille; S Houghton; S Gauthier; R Leblanc
Paired helical filaments and the cytoplasmic-nuclear interface in Alzheimer's disease.
Journal of neurocytology 1988;17(6):827-33.
1988: R Leblanc; S Gauthier; M Gauvin; Rémi Quirion; Roberta Palmour; H Masson
Neurobehavioral effects of intrathecal somatostatinergic treatment in subhuman primates.
Neurology 1988;38(12):1887-90.
1988: D M Araujo; P A Lapchak; Yvonne Robitaille; S Gauthier; Rémi Quirion
Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
Journal of neurochemistry 1988;50(6):1914-23.
1988: G Lacoste-Royal; M Mathieu; J P Julien; S Gauthier; D Gauvreau
RFLP for TaqI at the human neurofilament (NF-L) gene locus.
Nucleic acids research 1988;16(9):4184.
1988: J Metuzals; Y Robitaille; S Houghton; S Gauthier; C Y Kang; R Leblanc
Neuronal transformations in Alzheimer's disease.
Cell and tissue research 1988;252(2):239-48.
1988: C Redies; Mirko Diksic; B Collier; Albert Gjedde; C J Thompson; S Gauthier; W H Feindel
Influx of a choline analog to dog brain measured by positron emission tomography.
Synapse (New York, N.Y.) 1988;2(4):406-11.
1988: L S Wolfe; S Gauthier; M Haltia; J Palo
Dolichol and dolichyl phosphate in the neuronal ceroid-lipofuscinoses and other diseases.
American journal of medical genetics. Supplement 1988;5():233-42.
1988: S Gauthier; P Perot; G Bertrand
Role of surgical anterior rhizotomies in the management of spasmodic torticollis.
Advances in neurology 1988;50():633-5.
1987: C Pilapil; S Welner; J Magnan; S Gauthier; Rémi Quirion
Autoradiographic distribution of multiple classes of opioid receptor binding sites in human forebrain.
Brain research bulletin 1987;19(5):611-5.
1987: S Gauthier; L Gauthier
Current status of levodopa therapy in idiopathic Parkinson's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1987;14(3 Suppl):452-4.
1987: K Yashpal; S Gauthier; J L Henry
Oxytocin administered intrathecally preferentially increases heart rate rather than arterial pressure in the rat.
Journal of the autonomic nervous system 1987;20(2):167-78.
1987: L Gauthier; S Dalziel; S Gauthier
The benefits of group occupational therapy for patients with Parkinson's disease.
The American journal of occupational therapy : official publication of the American Occupational Therapy Association 1987;41(6):360-5.
1987: R Leblanc; J L Tyler; G Mohr; E Meyer; M Diksic; L Yamamoto; L Taylor; S Gauthier; A Hakim
Hemodynamic and metabolic effects of cerebral revascularization.
Journal of neurosurgery 1987;66(4):529-35.
1987: R A Cridland; Kiran Yashpal; V V Romita; S Gauthier; J L Henry
Distribution of label after intrathecal administration of 125I-substance P in the rat.
Peptides 1987;8(2):213-21.
1987: K Yashpal; S Gauthier; J L Henry
Substance P given intrathecally at the spinal T9 level increases arterial pressure and heart rate in the rat.
Journal of the autonomic nervous system 1987;18(2):93-103.
1987: Rémi Quirion; S Welner; S Gauthier; P Bédard
Neurotensin receptor binding sites in monkey and human brain: autoradiographic distribution and effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
Synapse (New York, N.Y.) 1987;1(6):559-66.
1986: P Etienne; Y Robitaille; P Wood; S Gauthier; N P Nair; R Quirion
Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease.
Neuroscience 1986;19(4):1279-91.
1986: R Quirion; J C Martel; Y Robitaille; P Etienne; P Wood; N P Nair; S Gauthier
Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1986;13(4 Suppl):503-10.
1986: S Gauthier; R Leblanc; Y Robitaille; R Quirion; G Carlsson; M Beaulieu; R Bouchard; D Dastoor; F Ervin; L Gauthier
Transmitter-replacement therapy in Alzheimer's disease using intracerebroventricular infusions of receptor agonists.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1986;13(4 Suppl):394-402.
1986: M Wainberg; Hugues Barbeau; S Gauthier
Quantitative assessment of the effect of cyproheptadine on spastic paretic gait: a preliminary study.
Journal of neurology 1986;233(5):311-4.
1986: A M Ghadirian; S Gauthier; S Bertrand
Anxiety attacks in a patient with a right temporal lobe meningioma.
The Journal of clinical psychiatry 1986;47(5):270-1.
1986: P Etienne; Y Robitaille; S Gauthier; N P Nair
Nucleus basalis neuronal loss and neuritic plaques in advanced Alzheimer's disease.
Canadian journal of physiology and pharmacology 1986;64(3):318-24.
1986: S Gauthier; Y Robitaille; R Quirion; R Leblanc
Antemortem laboratory diagnosis of Alzheimer's disease.
Progress in neuro-psychopharmacology & biological psychiatry 1986;10(3-5):391-403.
1985: B E Suranyi-Cadotte; S Gauthier; F Lafaille; S DeFlores; T V Dam; N P V Nair; Rémi Quirion
Platelet 3H-imipramine binding distinguishes depression from Alzheimer dementia.
Life sciences 1985;37(24):2305-11.
1985: J P Gagner; S Gauthier
Estimation of adrenal catecholamines by elevated-temperature liquid chromatography with amperometric detection.
Journal of chromatography 1985;342(2):363-9.
1985: L Berger; S Gauthier; R Leblanc
Akinetic mutism and parkinsonism associated with obstructive hydrocephalus.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1985;12(3):255-8.
1985: K Yashpal; S Gauthier; J L Henry
Substance P given intrathecally at the spinal T9 level increases adrenal output of adrenaline and noradrenaline in the rat.
Neuroscience 1985;15(2):529-36.
1985: B E Suranyi-Cadotte; J N Nestoros; N P Nair; S Lal; S Gauthier
Parkinsonism induced by high doses of diazepam.
Biological psychiatry 1985;20(4):455-7.
1985: J P Gagner; S Gauthier; T L Sourkes
Differential effects of transection of the spinal cord and splanchnic nerve on adrenal tyrosine hydroxylase and catecholamines.
Neuroscience 1985;14(3):907-20.
1985: M Van Houten; M N Khan; R J Walsh; G B Baquiran; L P Renaud; C Bourque; S Sgro; S Gauthier; M Chretien; Barry Posner
NH2-terminal specificity and axonal localization of adrenocorticotropin binding sites in rat median eminence.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(4):1271-5.
1985: J P Gagner; S Gauthier; T L Sourkes
Descending spinal pathways mediating the responses of adrenal tyrosine hydroxylase and catecholamines to insulin and 2-deoxyglucose.
Brain research 1985;325(1-2):187-97.
1985: M Ekker; S Gauthier; T L Sourkes
Transneuronal induction of adrenal ornithine decarboxylase through descending spinal pathways.
Neurochemistry international 1985;7(3):467-71.
1985: S Gauthier
Practical guidelines for the antemortem diagnosis of senile dementia of the Alzheimer type.
Progress in neuro-psychopharmacology & biological psychiatry 1985;9(5-6):491-5.
1984: W G Vincken; S Gauthier; R E Dollfuss; R E Hanson; C M Darauay; Manuel G Cosio
Involvement of upper-airway muscles in extrapyramidal disorders. A cause of airflow limitation.
The New England journal of medicine 1984;311(7):438-42.
1984: Simon N Young; S Gauthier; M E Kiely; S Lal; G M Brown
Effect of oral melatonin administration on melatonin, 5-hydroxyindoleacetic acid, indoleacetic acid, and cyclic nucleotides in human cerebrospinal fluid.
Neuroendocrinology 1984;39(1):87-92.
1984: A Sherwin; F Quesney; S Gauthier; A Olivier; Yvonne Robitaille; P McQuaid; C Harvey; N van Gelder
Enzyme changes in actively spiking areas of human epileptic cerebral cortex.
Neurology 1984;34(7):927-33.
1984: S Gauthier; L F Quesney
Assessment of cortical dopaminergic activity in Parkinson's disease by EEG.
Advances in neurology 1984;40():399-402.
1984: S Lal; P L Wood; M E Kiely; P Etienne; S Gauthier; J Stratford; R M Ford; D Dastoor; N P Nair
CSF acetylcholinesterase in dementia and in sequential samples of lumbar CSF.
Neurobiology of aging 1984;5(4):269-74.
1983: P L Wood; P Etienne; S Lal; N P Nair; M H Finlayson; S Gauthier; J Palo; M Haltia; A Paetau; E D Bird
A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease.
Journal of the neurological sciences 1983;62(1-3):211-7.
1983: S Gauthier; A Sniderman
Action tremor as a manifestation of chylomicron retention disease.
Annals of neurology 1983;14(5):591.
1983: M van Houten; D M Nance; S Gauthier; Barry Posner
Origin of insulin-receptive nerve terminals in rat median eminence.
Endocrinology 1983;113(4):1393-9.
1983: J Waserman; S Lal; S Gauthier
Gilles de la Tourette's syndrome in monozygotic twins.
Journal of neurology, neurosurgery, and psychiatry 1983;46(1):75-7.
1983: Simon N Young; M H Joseph; S Gauthier
Studies on kynurenine in human cerebrospinal fluid: lowered levels in epilepsy.
Journal of neural transmission 1983;58(3-4):193-204.
1983: P L Wood; N P Nair; P Etienne; S Lal; S Gauthier; Y Robitaille; E D Bird; J Palo; M Haltia; A Paetau
Lack of cholinergic deficit in the neocortex in Pick's disease.
Progress in neuro-psychopharmacology & biological psychiatry 1983;7(4-6):725-7.
1983: J P Gagner; S Gauthier; T L Sourkes
Participation of spinal monoaminergic and cholinergic systems in the regulation of adrenal tyrosine hydroxylase.
Neuropharmacology 1983;22(1):45-53.
1982: P L Wood; P Etienne; S Lal; S Gauthier; S Cajal; N P Nair
Reduced lumbar CSF somatostatin levels in Alzheimer's disease.
Life sciences 1982;31(19):2073-9.
1982: M I Botez; Simon N Young; J Bachevalier; S Gauthier
Effect of folic acid and vitamin B12 deficiencies on 5-hydroxyindoleacetic acid in human cerebrospinal fluid.
Annals of neurology 1982;12(5):479-84.
1982: M I Botez; Simon N Young; J Bachevalier; S Gauthier
Thiamine deficiency and cerebrospinal fluid 5-hydroxyindoleacetic acid: a preliminary study.
Journal of neurology, neurosurgery, and psychiatry 1982;45(8):731-3.
1982: Simon N Young; B A Davis; S Gauthier
Precursors and metabolites of phenylethylamine, m and p-tyramine and tryptamine in human lumbar and cisternal cerebrospinal fluid.
Journal of neurology, neurosurgery, and psychiatry 1982;45(7):633-9.
1982: T L Perry; S Hansen; R A Wall; S Gauthier
Human CSF GABA concentrations: revised downward for controls, but not decreased in Huntington's chorea.
Journal of neurochemistry 1982;38(3):766-73.
1982: Y Robitaille; P L Wood; P Etienne; S Lal; M H Finlayson; S Gauthier; N P Nair
Reduced cortical choline acetyltransferase activity in Gerstmann-Sträussler syndrome.
Progress in neuro-psychopharmacology & biological psychiatry 1982;6(4-6):529-31.
1982: Simon N Young; S Gauthier; G Chouinard; G M Anderson; W C Purdy
The effect of carbidopa and benserazide on human plasma 5-hydroxytryptophan levels.
Journal of neural transmission 1982;53(1):83-7.
1982: S Gauthier; T L Sourkes
Anatomical and biochemical basis of the extrapyramidal disorders.
Progress in neuro-psychopharmacology & biological psychiatry 1982;6(4-6):595-9.
1981: P Etienne; D Dastoor; S Gauthier; R Ludwick; B Collier
Alzheimer disease: lack of effect of lecithin treatment for 3 months.
Neurology 1981;31(12):1552-4.
1981: Simon N Young; S Gauthier
Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid.
Journal of neurology, neurosurgery, and psychiatry 1981;44(4):323-8.
1981: S Gauthier; Simon N Young; D W Baxter
[Palatal myoclonus associated with a decrease in 5-hydroxy-indole acetic acid in cerebrospinal fluid and responding to clonazepam].
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1981;8(1):51-4.
1981: S N Young; S Gauthier
Tryptophan availability and the control of 5-hydroxytryptamine and tryptamine synthesis in human CNS.
Advances in experimental medicine and biology 1981;133():221-30.
1980: E M Sternberg; M H Van Woert; Simon N Young; I Magnussen; H Baker; S Gauthier; C K Osterland
Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.
The New England journal of medicine 1980;303(14):782-7.
1980: S de Cheveigne; J Klein; A Leger; S Gauthier; C Guinet; M Belin; D Defourneau; D Aslanian; M Balkanski; A Lautie
Interaction of acetylcholine and beta-methylacetylcholine with aluminum oxide surface studied by inelastic electron tunneling spectrometry.
Biochemical and biophysical research communications 1980;94(1):29-33.
1980: Simon N Young; S Gauthier; G M Anderson; W C Purdy
Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs.
Journal of neurology, neurosurgery, and psychiatry 1980;43(5):438-45.
1980: Simon N Young; G M Anderson; S Gauthier; W C Purdy
The origin of indoleacetic acid and indolepropionic acid in rat and human cerebrospinal fluid.
Journal of neurochemistry 1980;34(5):1087-92.
1979: S Gauthier; J P Gagner; T L Sourkes
Role of descending spinal pathways in the regulation of adrenal tyrosine hydroxylase.
Experimental neurology 1979;66(1):42-54.
1979: G M Brown; Simon N Young; S Gauthier; H Tsui; L J Grota
Melatonin in human cerebrospinal fluid in daytime; its origin and variation with age.
Life sciences 1979;25(11):929-36.
1979: K D Laxer; T L Sourkes; T Y Fang; Simon N Young; S Gauthier; K Missala
Monoamine metabolites in the CSF of epileptic patients.
Neurology 1979;29(8):1157-61.
1979: M I Botez; Simon N Young; J Bachevalier; S Gauthier
Folate deficiency and decreased brain 5-hydroxytryptamine synthesis in man and rat.
Nature 1979;278(5700):182-3.
1978: P Etienne; S Gauthier; D Dastoor; B Collier; J Ratner
Lecithin in Alzheimer's disease.
Lancet 1978;2(8101):1206.
1978: P Etienne; S Gauthier; G Johnson; B Collier; T Mendis; D Dastoor; M Cole; H F Muller
Clinical effects of choline in Alzheimer's disease.
Lancet 1978;1(8062):508-9.
1977: M Quik; T L Sourkes; B O Dubrovsky; S Gauthier
Role of the raphe nuclei in the regulation of adrenal tyrosine hydroxylase.
Brain research 1977;122(1):183-90.